Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-22-038384)

Filing Details

Accession Number:: 0000899243-22-038384
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-12-13 20:24:08
Reporting Period:: 2022-12-09

Accepted Time:: 2022-12-13 20:24:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1750019	Tcr2 Therapeutics Inc.	TCRR	Biological Products, (No Disgnostic Substances) (2836)	474152751

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1875057	Peter Olagunju	C/O Tcr2 Therapeutics 100 Binney Street Cambridge MA 02142	Chief Technical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-12-09	1,561	$1.13	27,361	No	4	S	Direct
Common Stock	Disposition	2022-12-12	1,610	$1.10	25,751	No	4	S	Direct
Common Stock	Disposition	2022-12-13	1,659	$1.07	24,092	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	28,922	Direct

Footnotes

The sales reported represent the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1.